CISD1, also known as mitoNEET, is a protein linked to the outer mitochondrial membrane, possessing a unique CDGSH iron-sulfur domain. Crucial for mitochondrial function and iron homeostasis, it's implicated in various metabolic processes. CISD1 can regulate oxidative capacity and iron release, playing a role in cellular iron and reactive oxygen species balance. Additionally, its association with thiazolidinediones, drugs for type 2 diabetes, highlights its potential influence on metabolism. Dysregulation of CISD1 signaling can impact cellular energy balance and metabolic disorders, signifying its importance in maintaining cellular health and metabolic integrity. Research continues to uncover its precise roles and mechanisms in cellular signaling.
CISD1 (also known as mitoNEET) is a protein associated with the outer mitochondrial membrane and contains a CDGSH iron-sulfur domain. It has attracted attention due to its role in mitochondrial function, metabolism, and its binding to certain thiazolidinediones, a class of drugs used for type 2 diabetes. For a comprehensive list of small molecules that modulate CISD1 or detailed mechanisms of action, one would need to consult up-to-date research literature or specialized drug databases. As research progresses, more molecules might be identified that interact with or modulate the activity of CISD1. The exact mechanism of how thiazolidinediones influence CISD1 function remains a topic of study.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pioglitazone hydrochloride | 112529-15-4 | sc-204848 sc-204848A | 100 mg 500 mg | $63.00 $213.00 | 19 | |
Thiazolidinedione drugs that were found to bind to CISDThe thiazolidinediones were initially identified as insulin sensitizers and are studied in the research of type 2 diabetes. Their binding to CISD1 suggests a potential mechanism for some of their effects. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Thiazolidinedione drugs that were found to bind to CISDThe thiazolidinediones were initially identified as insulin sensitizers and are studied in the research of type 2 diabetes. Their binding to CISD1 suggests a potential mechanism for some of their effects." | ||||||